Literature DB >> 25091400

Prognostic impact of tumor location in stage IV colon cancer: a propensity score analysis in a multicenter study.

Soichiro Ishihara1, Takeshi Nishikawa2, Toshiaki Tanaka2, Junichiro Tanaka2, Tomomichi Kiyomatsu2, Kazushige Kawai2, Keisuke Hata2, Hioaki Nozawa2, Takamitsu Kanazawa2, Shinsuke Kazama2, Hironori Yamaguchi2, Eiji Sunami2, Joji Kitayama2, Yojiro Hashiguchi3, Kenichi Sugihara4, Toshiaki Watanabe5.   

Abstract

BACKGROUND: Right-sided colon cancer is considered to be biologically different from left-sided colon cancer; however, conflicting results have been reported regarding differences in prognosis. We aimed to clarify the prognostic impact of tumor location in stage IV colon cancer.
METHODS: Stage IV colon cancer treated from January 1997 to December 2007 (n = 2208) were retrospectively studied. Clinical and pathological features were compared between right-sided colon cancer (cecum, ascending, and transverse colon) and left-sided colon cancer (descending, sigmoid, and rectosigmoid colon). The impact of tumor location on cancer-specific survival (CSS) was analyzed in a multivariate analysis and propensity score analysis to mitigate the differences in background features.
RESULTS: Right-sided colon cancer was associated with older age, female sex, larger tumor size, poorly differentiated adenocarcinoma, mucinous adenocarcinoma, and signet-ring cell carcinoma, a more advanced state within stage IV disease, and a worse CSS. In the cohort matched by propensity scores for background clinicopathological features, tumor location in the right-sided colon was associated with a significantly worse CSS (hazard ratio 1.2, 95% confidence interval 1.1-1.4, p = 0.008) in patients treated with palliative primary tumor resection, but not in those treated with R0 resection or no resection.
CONCLUSION: Right-sided colon cancer were diagnosed at a more advanced state within stage IV disease and showed a significantly worse prognosis than left-sided colon cancer, suggesting that stage IV right-sided colon cancer is oncologically more aggressive than left-sided colon cancer.
Copyright © 2014 Surgical Associates Ltd. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Colon cancer; Prognostic factor; Stage IV; Tumor location

Mesh:

Year:  2014        PMID: 25091400     DOI: 10.1016/j.ijsu.2014.07.270

Source DB:  PubMed          Journal:  Int J Surg        ISSN: 1743-9159            Impact factor:   6.071


  14 in total

1.  Benefit of primary tumor resection in stage IV colorectal cancer with unresectable metastasis: a multicenter retrospective study using a propensity score analysis.

Authors:  Soichiro Ishihara; Takeshi Nishikawa; Toshiaki Tanaka; Junichiro Tanaka; Tomomichi Kiyomatsu; Kazushige Kawai; Keisuke Hata; Hioaki Nozawa; Shinsuke Kazama; Hironori Yamaguchi; Eiji Sunami; Joji Kitayama; Kenichi Sugihara; Toshiaki Watanabe
Journal:  Int J Colorectal Dis       Date:  2015-04-29       Impact factor: 2.571

2.  Predictors of long-term survival in patients with stage IV colorectal cancer with multi-organ metastases: a single-center retrospective analysis.

Authors:  Yuji Miyamoto; Naoko Hayashi; Yasuo Sakamoto; Mayuko Ohuchi; Ryuma Tokunagam; Junji Kurashige; Yukiharu Hiyoshi; Yoshifumi Baba; Shiro Iwagami; Naoya Yoshida; Megumi Yoshida; Hideo Baba
Journal:  Int J Clin Oncol       Date:  2015-05-07       Impact factor: 3.402

3.  Inflammation-based prognostic scores as indicators to select candidates for primary site resection followed by multimodal therapy among colorectal cancer patients with multiple metastases.

Authors:  Tadanobu Shimura; Yuji Toiyama; Susumu Saigusa; Hiroki Imaoka; Masato Okigami; Hiroyuki Fujikawa; Junichiro Hiro; Minako Kobayashi; Masaki Ohi; Toshimitsu Araki; Yasuhiro Inoue; Keiichi Uchida; Yasuhiko Mohri; Masato Kusunoki
Journal:  Int J Clin Oncol       Date:  2017-03-15       Impact factor: 3.402

4.  A prognostic analysis of 895 cases of stage III colon cancer in different colon subsites.

Authors:  Yan Zhang; Junli Ma; Sai Zhang; Ganlu Deng; Xiaoling Wu; Jingxuan He; Haiping Pei; Hong Shen; Shan Zeng
Journal:  Int J Colorectal Dis       Date:  2015-06-09       Impact factor: 2.571

5.  Molecular Oncology in Management of Colorectal Cancer.

Authors:  Ramraj Nagendra Gupta Vemala; Sanjeev Vasudev Katti; Bhawna Sirohi; Divya Manikandan; Govind Nandakumar
Journal:  Indian J Surg Oncol       Date:  2021-03-16

6.  Is the Location of the Tumor Another Prognostic Factor for Patients With Colon Cancer?

Authors:  Myung-Kyu Jung; Ui Sup Shin; Young-Jun Ki; Yong-Bae Kim; Sun-Mi Moon; Se-Jin Sung
Journal:  Ann Coloproctol       Date:  2017-12-31

7.  Intraperitoneal ziv-aflibercept effectively manages refractory ascites in colorectal cancer patients.

Authors:  Chieh-Sheng Lu; Jen-Kou Lin; Wei-Shone Chen; Tzu-Chen Lin; Jeng-Kai Jiang; Shung-Haur Yang; Huann-Sheng Wang; Shih-Ching Chang; Yuan-Tzu Lan; Chun-Chi Lin; Hung-Hsin Lin; Hao-Wei Teng
Journal:  Oncotarget       Date:  2017-05-30

8.  Resection of asymptomatic primary tumour in unresectable stage IV colorectal cancer: time to move on from propensity matched scores to randomized controlled trials.

Authors:  Kjetil Søreide
Journal:  Int J Cancer       Date:  2016-07-12       Impact factor: 7.396

9.  Impact of tumor sidedness on survival and recurrence patterns in colon cancer patients.

Authors:  Jong Min Lee; Yoon Dae Han; Min Soo Cho; Hyuk Hur; Byung Soh Min; Kang Young Lee; Nam Kyu Kim
Journal:  Ann Surg Treat Res       Date:  2019-05-29       Impact factor: 1.859

10.  Stage III Colon Cancer: The Individualized Strategy of Adjuvant Chemotherapy for Aged Under and Over 70.

Authors:  Chieh-Sheng Lu; Ping-Ying Chang; Yu-Guang Chen; Jia-Hong Chen; Yi-Ying Wu; Ching-Liang Ho
Journal:  PLoS One       Date:  2015-09-18       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.